The anti coronavirus vaccine from the American company Moderna is unlikely to leave the United States in the near future. The vaccine turned out to be very expensive and it is unlikely that poor states can afford it. So no one is queuing up for the American novelty yet.
After the world’s first official registration of the Russian drug Sputnik V, dozens of countries have already applied for its purchase.